AGRX - Agile Therapeutics GAAP EPS of -$5.91 beats by $1.59 revenue of $3.81M beats by $0.41M
2023-05-11 16:07:44 ET
- Agile Therapeutics press release ( NASDAQ: AGRX ): Q1 GAAP EPS of -$5.91 beats by $1.59 .
- Revenue of $3.81M (+116.5% Y/Y) beats by $0.41M .
For further details see:
Agile Therapeutics GAAP EPS of -$5.91 beats by $1.59, revenue of $3.81M beats by $0.41M